Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Indigenous Bloom Hemp Corp VRTHF

Indigenous Bloom Hemp Corporation is a Canada-based company, which produce and sell hemp extracts. The Company operates a large scale industrial hemp farm in southern Manitoba on approximately 200 acres of zoned farmland. The primary business of the Company is the sale of hemp biomass and flower (Hemp), Phyto cannabinoid rich (PCR) extracts derived from hemp biomass (Hemp Extracts). The Company is in the process of developing, through acquisition and construction, Hemp Products for general consumer end-use. It has two primary products which it plans to sell and is in the process of expanding its product line. The Company’s primary product to date is Hemp Biomass, which is sold pre-processed to customers and partners who process the biomass into Hemp Extracts. The Company has cultivated approximately 100,000 kilograms of Hemp Biomass.


GREY:VRTHF - Post by User

Bullboard Posts
Post by higherhighson Jan 31, 2017 9:42pm
132 Views
Post# 25781110

Veritas begins preparation for cannabis clinical trial

Veritas begins preparation for cannabis clinical trial

2017-01-31 17:19 ET - News Release

 

Dr. Lui Franciosi reports

VERITAS-CANNEVERT COMMENCES PREPARATION OF FIRST CLINICAL TRIALS OF CANNABIS TARGETING PAIN

Veritas Pharma Inc. is working with its research arm, Cannevert Therapeutics Ltd., to design and implement the first clinical trials of cannabis strains targeting pain. Leading contract research organizations (CROs) with clinical experience of evaluating cannabis and pain are being considered for cost estimates and timelines.

Veritas chief executive officer Dr. Lui Franciosi stated, "Cannevert's chemical and animal studies have identified suitable strains that warrant immediate human trials, which will be done to the highest standards at institutes of high repute."

Veritas and Cannevert intend to implement these clinical trials this year that meets the highest quality standards, such as good clinical practices (GCPs). CROs with experience in evaluating cannabis for the treatment of pain are currently being visited and screened for suitability. Once a site is identified and a contract negotiated, a formal announcement will be made.

Bullboard Posts